试验雷达 AI | ||
|---|---|---|
临床试验 NCT06843512 针对体重减轻，食物选择目前招募中。请查看临床试验雷达卡片视图和 AI 发现工具了解所有详情，或在此提出任何问题。 | ||
一个试验符合筛选条件
卡片视图
返回搜索
宾夕法尼亚州立大学Identifying Changes in Food Behaviors Associated With Beginning GLP-1 Medication 25
临床试验详情主要以英语提供。然而，试验雷达 AI可以提供帮助！只需点击“试验详解”即可查看和讨论您选择的语言的试验信息。
临床试验NCT06843512是一项针对体重减轻，食物选择的观察研究试验，目前试验状态为招募中。试验始于2025年7月15日，计划招募25名患者。该研究由宾夕法尼亚州立大学主导，预计于2026年12月1日完成。试验数据来源于ClinicalTrials.gov，最后更新时间为2025年9月10日。
简要概括
In recent years, GLP-1 medications have become a widely employed approach by physicians to address weight concerns in patients and lead to weight loss. Little is known, however, about how these medications may alter an individual's attitude towards food, food reactivity, or the specific types and amounts of foods an individual will choose. The purpose of this study is to observe the changes an individual experiences ...显示更多
官方标题
Exploring the Influence of GLP-1 Medication on Food Attitudes and Selection in a Virtual Reality Buffet
疾病
体重减轻食物选择其他研究标识符
- STUDY00026642
NCT编号
实际开始日期
2025-07-15
最近更新发布
2025-09-10
预计完成日期
2026-12
计划入组人数
25
研究类型
观察研究
试验状态
招募中
关键词
GLP-1
Weight Loss
Virtual Reality
Food behavior
Weight Loss
Virtual Reality
Food behavior
试验组/干预措施
| 参与者组/试验组 | 干预措施/治疗方法 |
|---|---|
不适用 | GLP-1 Medication Initiation One visit before starting GLP-1 medication and one visit 3 months after. No other changes administered between visits. |
主要终点
次要终点
| 结果指标 | 度量标准描述 | 时间框架 |
|---|---|---|
Change from Baseline in Total Weight of Food Selected in the VR Buffet at 3 Months | Baseline and 3 months | |
Change from Baseline in Total Calories of Food Selected in the VR Buffet at 3 Months | Baseline and 3 months | |
Change from Baseline in Energy Density of Food Selected in the VR Buffet at 3 Months | Baseline and 3 months | |
Change from Baseline in Variety of Food Selected in the VR Buffet at 3 Months | Baseline and 3 months |
| 结果指标 | 度量标准描述 | 时间框架 |
|---|---|---|
Change in Baseline Weight Watchers Food Noise Score at 3 Months | Based on participant's answers to the WW Food Noise questionnaire; Scale of 1-5, 1 being strongly disagree and 5 being strongly agree; Higher scores mean more food noise | Baseline and 3 months |
Change in Baseline 9-question External Food Cue Responsiveness Questionnaire Score at 3 Months | Answers are on a 1-4 scale with 1 being "Rarely" and 4 being "A lot"; higher scores suggest more external food cue reactivity | Baseline and 3 months |
Change in Baseline Adult Eating Behavior Score at 3 Months | Answers on a 1-5 scale with 1 being "Strongly disagree" and 5 being "Strongly agree"; 8 subscales, high scores indicate greater expression of subscale measure | Baseline and 3 months |
Change in Baseline Three-Factor Eating Questionnaire Score at 3 Months | Rated on a scale of 1-4 with 1 being "Definitely false" and 4 being "Definitely true"; 3 subscales, higher scales on each means greater expression of that behavior | Baseline and 3 months |
Change in Baseline General Food Craving-Trait Scale Score at 3 Months | Rated on a 0-5 scale with 0 being "Never/not applicable" and 5 being "Always"; higher scores mean more food dependent | Baseline and 3 months |
Change in Baseline Buffet Food Liking Scores at 3 Months | Rated on a 0-100 scale with 0 being "Dislike extremely" and 100 being "Like extremely"; high scores mean greater liking of the food | Baseline and 3 months |
参与助手
资格标准
适龄参与研究
成人, 老年人
最低年龄要求
18 Years
适龄性别
全部
- Adults (18+) with overweight or obesity (BMI >25 kg/m2)
- Not currently taking an incretin-based medication at baseline
- Recently (within two weeks) prescribed a GLP-1, can be included if they have a obesity-related co-occurring condition (diabetes, hypertension, cardiovascular disease, dyslipidemia)
- Have had no prior diagnosis of cognitive or physical disability, dyslexia, or epilepsy.
- Fluent in English
- Adults (18+) without overweight or obesity
- <18 years of age at time of testing
- Adults not taking a GLP-1 Medication
- Adults taking a compound GLP-1
- Adults on GLP-1 medication for longer than 2 weeks at baseline
- Have had a prior diagnosis of cognitive or physical disability, dyslexia, or epilepsy.
- Not fluent in English
宾夕法尼亚州立大学91 个活跃的临床试验可供探索研究责任方
Travis Masterson, 主要研究者, Assistant Professor and Director of the Health, Ingestive Behavior, and Technology Lab, Penn State University
研究中心联系人
联系人: Christina M Blackmon, 425-499-8049, [email protected]
1 位于 1 个国家/地区的研究中心
Pennsylvania
Health, Ingestive Behavior, and Technology Laboratory of Pennsylvania State University, State College, Pennsylvania, 16802, United States
Christina M Blackmon, 联系人, 425-499-8049, [email protected]
招募中